In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Cinnamaldehyde safety

This article was originally published in The Rose Sheet

Executive Summary

National Toxicology Program Board of Scientific Counselors affirms recent NTP draft report's findings that flavor and fragrance ingredient shows "no evidence" of carcinogenic activity in rodent studies. During meeting in Research Triangle Park, N.C. Sept. 5-6, NTP board also approves draft report conclusion that dipropylene glycol, a chemical used in cosmetics, air fresheners, household cleaners and antifreeze, does not cause cancer in rodents. NTP draft reports on rodent toxicology, carcinogenesis studies on ingredients were released in July (1"The Rose Sheet" Aug. 5, 2002, p. 8)...

You may also be interested in...



Cinnamaldehyde Shows “No Evidence” Of Carcinogenicity In NTP Studies

Flavor and fragrance ingredient cinnamaldehyde showed "no evidence" of carcinogenic activity in rodent studies conducted by the National Toxicology Program, according to a recently-released draft report of findings

Cosmetic And Personal Care Trademark Review: 16 April

Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.

Health And Wellness Weekly Trademarks Review: 16 April

Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.

Latest Headlines
See All
UsernamePublicRestriction

Register

RS010585

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel